{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:08:48Z","timestamp":1785298128590,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejphar.2020.173701","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T17:53:27Z","timestamp":1603994007000},"page":"173701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain"],"prefix":"10.1016","volume":"890","author":[{"given":"Nouredine","family":"Behloul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarra","family":"Baha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejphar.2020.173701_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1128\/AAC.00363-17","article-title":"Antiviral activity and resistance analysis of NS3\/4A protease inhibitor grazoprevir and NS5A inhibitor elbasvir in hepatitis C virus GT4 replicons","volume":"61","author":"Asante-Appiah","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.ejphar.2020.173701_bib2","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1080\/03007995.2020.1775075","article-title":"Efficacy and safety of elbasvir\/grazoprevir for 12 weeks in people with hepatitis C virus infection aged 35 years or younger compared with older people: a retrospective integrated analysis","volume":"36","author":"Asselah","year":"2020","journal-title":"Curr. Med. Res. Opin."},{"issue":"7","key":"10.1016\/j.ejphar.2020.173701_bib3","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejphar.2020.173701_bib4","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3390\/ijms20112783","article-title":"A structure-based drug discovery paradigm","volume":"20","author":"Batool","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2020.173701_bib5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cmdc.200700139","article-title":"Lessons learnt from assembling screening libraries for drug discovery for neglected diseases","volume":"3","author":"Brenk","year":"2008","journal-title":"ChemMedChem"},{"issue":"19","key":"10.1016\/j.ejphar.2020.173701_bib6","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173701_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.lfs.2016.02.035","article-title":"Neuroprotective effects of phytosterols and flavonoids from Cirsium setidens and Aster scaber in human brain neuroblastoma SK-N-SH cells","volume":"148","author":"Chung","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2020.173701_bib8","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173701_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2020.173701_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000179092","article-title":"Effect of Daflon 500 mg, a flavonoid drug, on neurological signs, levels of free radicals and electroretinogram in the gerbil after ischemia-reperfusion injury","volume":"15","author":"Delbarre","year":"1995","journal-title":"Int. J. Microcirc. Clin. Exp."},{"issue":"8","key":"10.1016\/j.ejphar.2020.173701_bib11","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.3390\/ijerph17082690","article-title":"Coronavirus diseases (COVID-19) current status and future perspectives: a narrative review","volume":"17","author":"Di Gennaro","year":"2020","journal-title":"Int. J. Environ. Res. Publ. Health"},{"issue":"8","key":"10.1016\/j.ejphar.2020.173701_bib12","first-page":"609","article-title":"Possible nitric oxide mechanism in the protective effect of hesperidin against ischemic reperfusion cerebral injury in rats","volume":"49","author":"Gaur","year":"2011","journal-title":"Indian J. Exp. Biol."},{"issue":"6493","key":"10.1016\/j.ejphar.2020.173701_bib13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1126\/science.abb9332","article-title":"Rapid repurposing of drugs for COVID-19","volume":"368","author":"Guy","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ejphar.2020.173701_bib14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12975-020-00818-9","article-title":"COVID-19-Related stroke","volume":"11","author":"Hess","year":"2020","journal-title":"Transl. Stroke Res."},{"issue":"2","key":"10.1016\/j.ejphar.2020.173701_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"10223","key":"10.1016\/j.ejphar.2020.173701_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2020.173701_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.aivir.2016.08.004","article-title":"Coronavirus spike protein and tropism changes","volume":"96","author":"Hulswit","year":"2016","journal-title":"Adv. Virus Res."},{"issue":"9","key":"10.1016\/j.ejphar.2020.173701_bib18","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/ptr.3724","article-title":"Preventive effects of hesperidin, glucosyl hesperidin and naringin on hypertension and cerebral thrombosis in stroke-prone spontaneously hypertensive rats","volume":"26","author":"Ikemura","year":"2012","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2020.173701_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.steroids.2017.01.003","article-title":"Neuroprotective effect and mechanism of daucosterol palmitate in ameliorating learning and memory impairment in a rat model of Alzheimer's disease","volume":"119","author":"Ji","year":"2017","journal-title":"Steroids"},{"issue":"W1","key":"10.1016\/j.ejphar.2020.173701_bib20","doi-asserted-by":"crossref","first-page":"W448","DOI":"10.1093\/nar\/gkv306","article-title":"MTiOpenScreen: a web server for structure-based virtual screening","volume":"43","author":"Labbe","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"7807","key":"10.1016\/j.ejphar.2020.173701_bib21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173701_bib22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.neuroscience.2014.03.032","article-title":"Diosmin protects against cerebral ischemia\/reperfusion injury through activating JAK2\/STAT3 signal pathway in mice","volume":"268","author":"Liu","year":"2014","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.ejphar.2020.173701_bib23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ejphar.2020.173701_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10072-019-04054-4","article-title":"Hesperidin reduces adverse symptomatic intracerebral hemorrhage by promoting TGF-beta1 for treating ischemic stroke using tissue plasminogen activator","volume":"41","author":"Qin","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ejphar.2020.173701_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1099-4831(06)63002-2","article-title":"Ergot alkaloids--biology and molecular biology","volume":"63","author":"Schardl","year":"2006","journal-title":"Alkaloids - Chem. Biol."},{"key":"10.1016\/j.ejphar.2020.173701_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/d41591-020-00019-9","article-title":"15 drugs being tested to treat COVID-19 and how they would work","author":"Shaffer","year":"2020","journal-title":"Nat. Med."},{"issue":"7807","key":"10.1016\/j.ejphar.2020.173701_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ejphar.2020.173701_bib28","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1021\/ci200193z","article-title":"AADS--an automated active site identification, docking, and scoring protocol for protein targets based on physicochemical descriptors","volume":"51","author":"Singh","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"26","key":"10.1016\/j.ejphar.2020.173701_bib29","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.2174\/13816128113199990379","article-title":"Genomes to hits in silico - a country path today, a highway tomorrow: a case study of chikungunya","volume":"19","author":"Soni","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2020.173701_bib30","first-page":"4237204","article-title":"Is nonmicronized diosmin 600 mg as effective as micronized diosmin 900 mg plus hesperidin 100 mg on chronic venous disease symptoms? Results of a noninferiority study","volume":"2020","author":"Steinbruch","year":"2020","journal-title":"Int. J. Vasc. Med."},{"issue":"7","key":"10.1016\/j.ejphar.2020.173701_bib31","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1371\/journal.pmed.0030237","article-title":"Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants","volume":"3","author":"Ter Meulen","year":"2006","journal-title":"PLoS Med."},{"issue":"7","key":"10.1016\/j.ejphar.2020.173701_bib32","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/ajh.25829","article-title":"Hematological findings and complications of COVID-19","volume":"95","author":"Terpos","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.ejphar.2020.173701_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ejphar.2020.173701_bib34","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1021\/acs.jcim.0c00179","article-title":"Fast identification of possible drug treatment of coronavirus disease-19 (COVID-19) through computational drug repurposing study","volume":"60","author":"Wang","year":"2020","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"10.1016\/j.ejphar.2020.173701_bib35","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2020.173701_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/B978-0-12-385885-6.00009-2","article-title":"Coronavirus pathogenesis","volume":"81","author":"Weiss","year":"2011","journal-title":"Adv. Virus Res."},{"issue":"2","key":"10.1016\/j.ejphar.2020.173701_bib37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/v12020244","article-title":"Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV","volume":"12","author":"Xu","year":"2020","journal-title":"Viruses"},{"issue":"6485","key":"10.1016\/j.ejphar.2020.173701_bib38","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"issue":"6491","key":"10.1016\/j.ejphar.2020.173701_bib39","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ejphar.2020.173701_bib40","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s11011-020-00575-6","article-title":"Improvement of cerebral ischemia\/reperfusion injury by daucosterol palmitate-induced neuronal apoptosis inhibition via PI3K\/Akt\/mTOR signaling pathway","volume":"35","author":"Zhang","year":"2020","journal-title":"Metab. Brain Dis."},{"issue":"10229","key":"10.1016\/j.ejphar.2020.173701_bib41","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920307937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920307937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:49:28Z","timestamp":1757976568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920307937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":41,"alternative-id":["S0014299920307937"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173701","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173701"}}